metoclopramide has been researched along with Agranulocytosis in 2 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manoharan, A | 1 |
| Harvey, RL | 1 |
| Luzar, MJ | 1 |
2 other studies available for metoclopramide and Agranulocytosis
| Article | Year |
|---|---|
Metoclopramide-induced agranulocytosis.
Topics: Aged; Aged, 80 and over; Agranulocytosis; Humans; Male; Metoclopramide | 1988 |
Metoclopramide-induced agranulocytosis.
Topics: Agranulocytosis; Blood Cell Count; Female; Humans; Metoclopramide; Middle Aged | 1988 |